Researchers compared the white matter networks of patients with remitted major depressive disorder and remitted bipolar disorder to find disease-specific alterations.
Your search for major depressive disorder returned 25 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Researchers examined associations between polygenic risk scores and neuropsychiatric conditions using data from phenome-wide association studies.
Researchers sought to assess the impact of early vs late initiation of natalizumab by looking at clinical and imaging information of patients with MS.
Researchers evaluated the efficacy of dextromorphan-bupropion among patients with major depressive disorder and comorbid anxiety.
Researchers sought to assess the impact of the COVID-19 pandemic on sleep in children with neurodevelopmental disorders and insomnia symptoms, and identify the factors that led to changes in sleep habits.
Researchers searched for protective effects in gut microbiota from the pathogenesis of major depressive disorder.
The researchers sought to examine whether inflammation and white matter microstructure play a role in treatment response in major depressive disorder.
Patients with somatoform disorders, major depressive disorder, and healthy controls were recruited between 2016 and 2017 at the Ambulante Psychosoziale Rehabilitation in Austria and Schoen Clinic Roseneck in Germany.
Outpatients were recruited at the Instituto Nacional de Psiquiatía (National Institute of Psychiatry) in Mexico and were evaluated for alcohol dependence and major depressive disorder.
This prospective, multi-center, open-label trial, CAN-BIND-1 was conducted between 2012 and 2017.